Real-time enrollment status for this beta-thalassemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 9:32 AM UTC
| NCT Number | NCT04064060 |
| Recruiting Status | Recruiting |
| Condition | Beta-thalassemia |
| Phase | Clinical Trial |
| Target Enrollment | 665 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Celgene |
| Last Updated on CT.gov | November 12, 2025 (Nov 12, 2025) |
As of March 2, 2026: Clinical trial NCT04064060 is currently recruiting participants. This clinical trial study for beta-thalassemia is actively seeking new participants at 12 locations across the United States. The study is sponsored by Celgene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04064060 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04064060 was last updated Nov 12, 2025 (November 12, 2025). HelloStudys verifies this status automatically.